Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: Herd immunity and reduction of otitis morbidity

Pediatric Infectious Disease Journal

Volumn 19, Issue 5 SUPPL., 2000, Pages

  Dagan, Ron ^a   Fraser, Drora ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Acute otitis media; Antibiotic resistance; Carriage; Conjugates vaccine

Indexed keywords

PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; CONFERENCE PAPER; HOST RESISTANCE; HUMAN; MULTIDRUG RESISTANCE; OTITIS MEDIA; PENICILLIN RESISTANCE; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0034026940     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200005001-00012     Document Type: Conference Paper

References (57)

1. Long SS, Henretig FM, Teter MJ, McGowen KL. Nasopharyngeal flora and acute otitis media. Infect Immun 1983;41: 987-91.
2. Faden H, Duffy L, Wasielewski R, et al. Relationship between nasopharyngeal colonization and the development of otitis media in children. J Infect Dis 1997;175:1440-5.
3. Zenni MK, Cheatham SH, Thompson JM, et al. Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. J Pediatr 1995;127: 533-7.
4. Mastro TD, Ghafoor A, Nomani NK, et al. Antimicrobial resistance of pneumococci in children with acute lower respiratory tract infection in Pakistan. Lancet 1991;337:156-9.
5. Lehmann D, Gratten M, Montgomery J. Susceptibility of pneumococcal carriage isolates to penicillin provides a conservative estimate of susceptibility of invasive pneumococci. Pediatr Infect Dis J 1997;16:297-305.
6. Lloyd-Evans N, O'Dempsey TJD, Baldeh I, et al. Nasopharyngeal carriage of pneumococci in Gambian children and in their families. Pediatr Infect Dis J 1996;15:866-71.
7. Gray BM, Converse GM III, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage and infection during the first 24 months of life. J Infect Dis 1980;142:923-33.
8. Hodges RG, Macleod CM, Bernhard WG. Epidemic pneumococcal pneumonia: III. Pneumococcal carrier studies. Am J Hyg 1946;44:207-30.
9. Gray BM, Turner ME, Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: the effects of season and age on pneumococcal acquisition and carriage in the first 24 months of life. Am J Epidemiol 1982;116:692-703.
10. Hendley JO, Sande MA, Stewart PM, Gwaltney JM. Spread of Streptococcus pneumoniae in families: carriage rates and distribution of types. J Infect Dis 1975;132:55-61.
11. Montgomery JM, Lehmann D, Smith T, et al. Bacterial colonization of the upper respiratory tract and its association with acute lower respiratory tract infections in Highland children of Papua New Guinea. Rev Infect Dis 1990;23: S1006-16.
12. Mastro TD, Nomani NK, Ishaq Z, et al. The use of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in Pakistan for surveillance for antimicrobial resistance. Pediatr Infect Dis J 1993;12:824-30.
13. Fredericksen B, Henrichsen J. Throat carriage of Streptococcus pneumoniae and Streptococcus pyogenes among infants and children in Zambia. J Trop Pediatr 1988;34:114-7.
14. Aniansson G, Aim B, Anderson B, et al. Nasopharyngeal colonization during the first year of life. J Infect Dis 1992; 165:838-42.
15. Bodwell Dunlap M, Stimson Harbery H. Host influence on upper respiratory flora. N Engl J Med 1956;255:640-6.
16. Loda FA, Collier AM, Glezen WP, et al. Occurrence of Diplococcus pneumoniae in the upper respiratory tract of children. J Pediatr 1975;87:1087-93.
17. Dagan R, Melamed R, Muallem M, Piglansky L, Yagupsky P. Nasopharyngeal colonization in southern Israel with antibiotic-resistant pneumococci during the first 2 years of life: relation to serotypes likely to be included in pneumococcal conjugate vaccines. J Infect Dis 1996;174:1352-5.
18. Kisiak JW, Razavi LM, Daly AK, Finland M. Susceptibility of pneumococci to nine antibiotics. Am J Med Sci 1965;250: 261-8.
19. Hansman D, Bullen M. A resistant pneumococcus. Lancet 1967;2:264-5.
20. Munford RS, Murphy TV. Antimicrobial resistance in Streptococcus pneumoniae: can immunization prevent its spread? J Invest Med 1994;42:613-21.
21. Friedland IR, McCracken GH Jr. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994;331:377-82.
22. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992;15:77-83.
23. Tomasz A. The pneumococcus at the gates. N Engl J Med 1995;333:514-5.
24. Dagan R, Leibovitz E, Leiberman A, Yagupsky P. Clinical significance of antibiotic resistance in acute otitis media and implication of antibiotic treatment on carriage and spread of resistant organisms. Pediatr Infect Dis J 2000;19:S57-65.
25. Klugman KP, Koornof HJ, Kuhnle V. Clinical and nasopharyngeal isolates of unusual multiply resistant pneumococci. Am J Child 1986;140:1186-90.
26. Geslin P, Buu-Hoi A, Frémaux A, Acar JF. Antimicrobial resistance in Streptococcus pneumoniae: an epidemiological survey in France, 1970-1990. Clin Infect Dis 1992;15:95-8.
27. Gehanno P, Olivier C, Boucot I, Lenoir G, Leblanc F, Berche P. Risk factors for nasopharyngeal carriage of resistant in S. pneumoniae [Abstract 160]. In: Proceedings of the 15th Annual Meeting of the European Society for Pediatric Infectious Diseases, Paris, May 22 to 23, 1997, p. 80.
28. Arason VA, Kristinsson KG, Sigurdsson JA,. Stefànsddóttir G, Mölstad S, Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. Br Med J 1996;313:387-91.
29. Leach AJ, Shelby-James TM, Mayo M, et al. A prospective study of the impact of community-based azithromycin treatment of trachoma on carriage and resistance of Streptococcus pneumoniae. Clin Infect Dis 1997;24:356-62.
30. Brook I, Gober AE. Prophylaxis with amoxicillin or sulfisoxazole for otitis media: effect on the recovery of penicillin-resistant bacterial from children. Clin Infect Dis 1996;22: 143-5.
31. Abdel-Haq N, Abuhammour W, Asmar B, Thomas R, Dabbagh S, Gonzalez R. Nasopharyngeal colonization with Streptococcus pneumoniae in children receiving trimethoprim-sulfamethoxazole prophylaxis. Pediatr Infect Dis J 1999;18:647-9.
32. Dabernat H, Geslin P, Megraud F, et al. Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media. J Antimicrob Chemother 1998;41: 253-8.
33. Cohen R, Bingen E, Varon E, et al. Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children. Pediatr Infect Dis J 1997;16:555-60.
34. Dagan R, Leibovitz E, Greenberg D, Yagupsky P, Fliss DM, Leiberman A. Dynamics of pneumococcal nasopharyngeal colonization during the first days of antibiotic treatment in pediatric patients. Pediatr Infect Dis J 1998;17:880-5.
35. Dagan R, Leibovitz E, Piglansky L, Yagupsky P. Effect of antibiotic treatment on pneumococcal nasopharyngeal carriage during and after acute otitis media: comparison of 3 oral drugs [Abstract 1028]. In: 39th Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 26 to 29, 1999. Washington, DC: American Society for Microbiology, 1999.
36. Melander E, Mölstad S, Persson K, Hansson HB, Söderström M, Ekdahl K. Previous antibiotic consumption and other risk factors for carriage of penicillin-resistant Streptococcus pneumoniae in children. Eur J Clin Microbiol Infect Dis 1998;17: 834-8.
37. Dagan R, Fraser D, Givon N, Yagupsky P. Coverage of antibiotic-resistant Streptococcus pneumoniae causing acute otitis media by 7, 9, and 11-valent pneumococcal conjugate vaccines in southern Israel [Abstract 1038], In: 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 26 to 29, 1999. Washington, DC: American Society for Microbiology, 1999.
38. Dagan R, Leibovitz E, Cheletz G, Leiberman A, Yagupsky P. Antibiotic treatment in acute otitis media induces middle ear fluid super-infection with pre-existing nasopharyngeal antibiotic-resistant Streptococcus pneumoniae [Abstract 1183]. In: 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, September 26 to 29, 1999. Washington, DC: American Society for Microbiology, 1999.
39. Ghaffar F, Friedland IR, McCracken GH Jr. Dynamics of nasopharyngeal colonization by Streptococcus pneumoniae. Pediatr Infect Dis J 1999;18:638-46.
40. Dagan R, Yagupsky P, Goldbart A, Wasas A, Klugman K. Increasing prevalence of penicillin-resistant pneumococcal infections in children in southern Israel: implications for future immunization policies. Pediatr Infect Dis J 1994;13:782-6.
41. Breiman R, Butler J, Tenover F, Elliott J, Facklam R. Emergence of drug-resistant pneumococcal infections in the United States. JAMA 1994;271:1831-5.
42. Haglund LA, Istre GR, Pickett DA, Welch DF, Fine DP, and the Pneumococcus Study Group. Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. J Infect Dis 1993;168:1532-6.
43. Welby P, Keller P, Cromien J, Tebas P, Storch G. Resistance to penicillin and non-beta-lactam antibiotics of Streptococcus pneumoniae at a children's hospital. Pediatr Infect Dis J 1994;13:281-7.
44. Eskola J, Kilpi T. Potential of bacterial vaccines in the prevention of acute otitis media. Pediatr Infect Dis J 2000; 19:S72-8.
45. Mohle-Boetani JC, Ajello G, Breneman E, et al. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr Infect Dis J 1993;12:589-93.
46. Murphy TV, Pastor P, Medley F, Osterholm MT, Granoff DM. Decreased Haemophilus colonization in children vaccinated with Haemophilus influenzae type b conjugate vaccine. J Pediatr 1993;122:517-23.
47. Takala AK, Santosham M, Almeido-Hill J, et al. Vaccination with Haemophilus influenzae type b meningococcal protein conjugate vaccine reduces oropharyngeal carriage of Haemophilus influenzae type b among American Indian children. Pediatr Infect Dis J 1993;12:593-9.
48. Takala AK, Eskola J, Leinonen M, et al. Reduction in oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis 1991;164:982-6.
49. Barbour ML, Mayon-White RT, Crook DW, Coles C, Moxon ER. The influence of Haemophilus influenzae type b conjugate vaccine (PRP-T) on oropharyngeal carriage of Haemophilus influenzae type b in infants under 12 months of age [Abstract 304]. In: 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, October, 1993. Washington, DC: American Society for Microbiology, 1993.
50. Dagan R, Melamed R, Muallem M, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis 1996;174:1271-8.
51. Dagan R, Muallem M, Melamed R, Leroy O, Yagupsky P. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr Infect Dis J 1997;16:1060-4.
52. Obaro SK, Adegbola RA, Banya WA, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination. Lancet 1996;348:272.
53. Mbelle N, Wasas A, Heubner R, Kimura A, Chang I, Kimura A. Immunogenicity and impact on carriage of 9-valent pneumococcal conjugate given to infants in Soweto, South Africa [Abstract LB-21]. In: 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, September 28 to October 1, 1997. Washington, DC: American Society for Microbiology, 1997.
54. Dagan R, Givon N, Yagupsky P, et al. Effect of a 9-valent pneumococcal vaccine conjugated to CRM197 (PncCRM9) on nasopharyngeal carriage of vaccine type and non-vaccine type S. pneumoniae (Pnc) strains among day-care center (DCC) attendees [Abstract G-52]. In: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 24 to 27, 1998. Washington, DC: American Society for Microbiology, 1998.
55. 197 (MncCRM-C) during 2nd and 3rd year of life: a double blind randomized study [Abstract G-051]. In: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 24 to 27, 1998. Washington, DC: American Society for Microbiology, 1998.
56. Black S, Shinefield H, Ray P, et al. Efficacy of heptavalent conjugate vaccine (Wyeth Lederle) in 37 000 infants and children: results of the northern California Kaiser Permanente efficacy trial [Abstract LB-9]. In: 38th Interscience Conference on Antimicrobial Agents and Chemotherapy; San Diego, September 24 to 27, 1998. Washington, DC: American Society for Microbiology, 1998:23.
57. Shinefield H. Infant immunization with a heptavalent conjugate pneumococcal vaccine [Abstract PS-14]. Presented at the 17th Annual Meeting of the European Society of Pediatric Infectious Diseases, Crete, Greece, May 19 to 21, 1999.